The rising prevalence in GLP-1 agonists for metabolic conditions has led to a discussion about application forms : skin-applied devices versus pills . Traditionally , GLP-1 drugs were only available in https://katrinawmxl738852.blogspothub.com/39736700/glp-1-transdermal-delivery-systems-vs-pills-is-best-for-the-patient